Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MIDAZOLAM vs MIFEPRISTONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MIDAZOLAM vs MIFEPRISTONE: Safety Overview

Metric MIDAZOLAM MIFEPRISTONE
Total FAERS Reports 11,192 4,492
Deaths Reported 1,808 294
Death Rate 16.2% 6.5%
Hospitalizations 4,691 1,322
Average Patient Age 41.9 yrs 46.2 yrs
% Female Patients 49.9% 84.4%
FDA Approval Date Apr 17, 2023 Apr 11, 2019
Manufacturer SOMERSET THERAPEUTICS, LLC Corcept Therapeutics Incorporated
Route INTRAMUSCULAR ORAL
Marketing Status Discontinued Prescription